Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

microRNA

  • Open Access
    Bioinformatics Analysis of Novel Targets for Treating Cervical Cancer by Immunotherapy Based on Immune Escape
    YING-HAO HAN, DA-YU MA, SEUNG-JAE LEE, YING-YING MAO, SHUAI-YANG SUN, MEI-HUA JIN, HU-NAN SUN and TAEHO KWON
    Cancer Genomics & Proteomics July 2023, 20 (4) 383-397; DOI: https://doi.org/10.21873/cgp.20390
  • Open Access
    Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome
    JAROSLAV JURACEK, MARIE MADRZYK, KAROLINA TRACHTOVA, MICHAELA RUCKOVA, JULIA BOHOSOVA, DOMINIK A. BARTH, MARTIN PICHLER, MICHAL STANIK and ONDREJ SLABY
    Cancer Genomics & Proteomics May 2023, 20 (3) 308-316; DOI: https://doi.org/10.21873/cgp.20383
  • Open Access
    An miRNA Signature Predicts Grading of Pancreatic Neuroendocrine Neoplasms
    JAMES SALLER, DALEY WHITE, BROOKE HOUGH, SEAN YODER, JUNMIN WHITING, DUNG-TSA CHEN, ANTHONY MAGLIOCCO and DOMENICO COPPOLA
    Cancer Genomics & Proteomics March 2023, 20 (2) 154-164; DOI: https://doi.org/10.21873/cgp.20370
  • Open Access
    Small RNA Sequencing Identifies a Six-MicroRNA Signature Enabling Classification of Brain Metastases According to their Origin
    IVANA ROSKOVA, MAREK VECERA, LENKA RADOVA, KAROLINA TRACHTOVA, FRANTISEK SIEGL, MARKETA HERMANOVA, MICHAL HENDRYCH, LEOS KREN, VACLAV VYBIHAL, HANA VALEKOVA, PETRA KASPAROVA, IVANA KOLOUSKOVA, TOMAS KAZDA, ONDREJ SLABY, RADIM JANCALEK, JIRI SANA and MARTIN SMRCKA
    Cancer Genomics & Proteomics January 2023, 20 (1) 18-29; DOI: https://doi.org/10.21873/cgp.20361
  • You have access
    MiR-139 Induces an Interferon-β Response in Prostate Cancer Cells by Binding to RIG-1
    ROBERT K. NAM, TANIA BENATAR, YUTAKA AMEMIYA and ARUN SETH
    Cancer Genomics & Proteomics May 2021, 18 (3) 197-206; DOI: https://doi.org/10.21873/cgp.20252
  • Open Access
    Association of miR-125b, miR-17 and let-7c Dysregulations With Response to Anti-epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With Metastatic Colorectal Cancer
    ONDREJ FIALA, ONDREJ SOREJS, PETR HOSEK, VACLAV LISKA, ONDREJ VYCITAL, JAN BRUHA, RADEK KUCERA, ONDREJ TOPOLCAN, JINDRICH FINEK, DIANA MACECKOVA and PAVEL PITULE
    Cancer Genomics & Proteomics September 2020, 17 (5) 605-613; DOI: https://doi.org/10.21873/cgp.20217
  • Open Access
    Tumor microRNAs Identified by Small RNA Sequencing as Potential Response Predictors in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy
    TANA MACHACKOVA, KAROLINA TRACHTOVA, VLADIMIR PROCHAZKA, TOMAS GROLICH, MARTINA FARKASOVA, LUKAS FIALA, ROMAN SEFR, IGOR KISS, MATEJ SKROVINA, MICHAL DOSOUDIL, IOANA BERINDAN-NEAGOE, MAREK SVOBODA, ONDREJ SLABY and ZDENEK KALA
    Cancer Genomics & Proteomics May 2020, 17 (3) 249-257; DOI: https://doi.org/10.21873/cgp.20185
  • Open Access
    MicroRNA 362-3p Reduces hERG-related Current and Inhibits Breast Cancer Cells Proliferation
    ABDULLAH A. ASSIRI, NOHA MOURAD, MINGHAI SHAO, PATRICK KIEL, WANQING LIU, TODD C. SKAAR and BRIAN R. OVERHOLSER
    Cancer Genomics & Proteomics November 2019, 16 (6) 433-442; DOI: https://doi.org/10.21873/cgp.20147
  • Open Access
    MiR-376b-3p Is Associated With Long-term Response to Sunitinib in Metastatic Renal Cell Carcinoma Patients
    JULIA KOVACOVA, JAROSLAV JURACEK, ALEXANDR POPRACH, JINDRICH KOPECKY, ONDREJ FIALA, MAREK SVOBODA, PAVEL FABIAN, LENKA RADOVA, PETR BRABEC, TOMAS BUCHLER and ONDREJ SLABY
    Cancer Genomics & Proteomics September 2019, 16 (5) 353-359; DOI: https://doi.org/10.21873/cgp.20140
  • Open Access
    MicroRNA-15b-5p Predicts Locoregional Relapse in Head and Neck Carcinoma Patients Treated With Intensity-modulated Radiotherapy
    PARWEZ AHMAD, JIRI SANA, MAREK SLAVIK, DOMINIK GURIN, LENKA RADOVA, NATALIA ANNA GABLO, TOMAS KAZDA, PAVEL SMILEK, ZUZANA HORAKOVA, BRETISLAV GAL, MARKETA HERMANOVA, PAVEL SLAMPA and ONDREJ SLABY
    Cancer Genomics & Proteomics March 2019, 16 (2) 139-146; DOI: https://doi.org/10.21873/cgp.20119

Pages

  • Next
  • 1
  • 2
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire